fda shortage semaglutide injection products resolved feb 21 2025 ends shortage, closing the door on compounded Wegovy, Ozempic Minnesota doctor says FDA weight-loss

A few pounds up or down at weigh-ins usually doesnt reflect a real change in progress

Changes in glycated hemoglobin (HbA1c) and body weight were assessed over a 3-month period

Demonstrated positive response defined as 5% reduction from baseline body weight (adults) or baseline BMI (pediatrics), or maintenance of weight loss with continued participation in a weight management program

GLP-1 receptor agonists work through several complementary mechanisms

The treatment, which lasts up to 45 minutes, requires little downtime

In a recent news release, the manufacturer announced the submission of a new drug application to the US Food and Drug Administration (FDA) and a marketing authorisation application to the European Medicines Agency (EMA) for tirzepatide for the treatment of adults with type 2 diabetes [12]